NK-Cell Lymphoma, Unclassifiable

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB09035Nivolumab2Active Not Recruiting1
DB06132Nivolumab2Terminated1
DB09035Nivolumab2Terminated1
DB13896Talimogene laherparepvec2Active Not Recruiting1